0001209191-19-045468.txt : 20190812 0001209191-19-045468.hdr.sgml : 20190812 20190812142536 ACCESSION NUMBER: 0001209191-19-045468 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190809 FILED AS OF DATE: 20190812 DATE AS OF CHANGE: 20190812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCAFEE LAWRANCE W CENTRAL INDEX KEY: 0001263096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11151 FILM NUMBER: 191015704 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: U S PHYSICAL THERAPY INC /NV CENTRAL INDEX KEY: 0000885978 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 760364866 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1300 WEST SAM HOUSTON PARKWAY STREET 2: SUITE 300 CITY: HOUSTON STATE: TX ZIP: 77043 BUSINESS PHONE: 7132977000 MAIL ADDRESS: STREET 1: 1300 WEST SAM HOUSTON PARKWAY STREET 2: SUITE 300 CITY: HOUSTON STATE: TX ZIP: 77043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-09 0 0000885978 U S PHYSICAL THERAPY INC /NV USPH 0001263096 MCAFEE LAWRANCE W 1300 W. SAM HOUSTON PKWY S. SUITE 300 HOUSTON TX 77042 1 1 0 0 Chief Financial Officer Common Stock 2019-08-09 4 S 0 1200 132.53 D 23028 D Common Stock 2019-08-09 4 S 0 1300 130.55 D 21728 D The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.02 to $133.45 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Includes 19,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021; 1,288 on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.07 to $131.01 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. /s/ Lawrance W McAfee 2019-08-12